The University of Maryland, Baltimore will conduct research on the regulation of cellular plasticity by androgen receptor splicing variants in prostate cancer under a three-year, $1,390,500 Project Grant from the Defense Health Agency. The grant supports the Military Medical Research and Development program, which aims to transform military and public health through innovative medical research solutions for battlefield wounds and illnesses.
The University will investigate medical solutions for prostate cancer under the grant funding. Specifically, researchers will examine how androgen receptor splicing variants regulate cellular plasticity in prostate cancer. Insights from this research could help improve diagnosis and treatment of prostate cancer, a disease that significantly impacts both military service members and civilians. The University of Maryland, Baltimore is a subsidiary of the University System of Maryland and will perform the work at its campus located in Baltimore, Maryland.
Generated 1/7/24, 1:58 AM